I found this paragraph particularly interesting!
- among private payers in the US, risk-sharing agreements to manage uncertain outcomes and costs (where pharmaceutical companies and payers agree to share the risk regarding a newly-approved products cost effectiveness in clinical practice) will become more common.
Hopefully the news about Roche comes soon!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.035(2.58%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $132.9K | 95.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2942 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 8327 | 5 |
View Market Depth
| Last trade - 12.39pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |